Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by AphLhsDiageoon Mar 06, 2019 12:02pm
167 Views
Post# 29449928

2 Million Kilos produced / year in Canada by end of 2019

2 Million Kilos produced / year in Canada by end of 2019 Many of the 150 or so LPs will not have contracts or demand to sell all their recreational product (flower) by late 2019/2020. The rec market is only a portion of the market and is swamped by competition trying to make the fast buck while the demand is unmet. The oversupply in late 2019 will drive the price of bud down which will be really really bad for other LPs. 

Those with contracts (medical) / global footprint / medical demands / extraction facility and products beyond just bud will flourish with limited competition. Aphria has everything in place to rise to the top once real competition sets in. 

I see this industry having only 4 or 5 LPs by end of 2020. Many of these 150 or so LPs will sell for considerable less once oversupply sets in. Thoughts?  
Bullboard Posts